Pascal Deschatelets

Insider Reports History

Location
Crestwood, KY
Signature
/s/ David Watson, attorney-in-fact for Pascal Deschatelets
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Pascal Deschatelets:

Company Role Class Num Shares Value Price $ Report Date Ownership
Apellis Pharmaceuticals, Inc. Chief Scientific Officer Common Stock 1,160,496 $4,363,464 $3.76 21 May 2025 Direct
Apellis Pharmaceuticals, Inc. Chief Scientific Officer Stock Option (Right to Buy) 82,500 $1,599,675 $19.39 09 Jun 2025 Direct

Insider Reports Filed by Pascal Deschatelets

Symbol Company Period Transactions Value $ Form Type Role Filing Time
APLS Apellis Pharmaceuticals, Inc. 09 Jun 2025 1 +$1,599,675 4 Chief Scientific Officer 11 Jun 2025, 16:19
APLS Apellis Pharmaceuticals, Inc. 21 May 2025 2 +$48,053 4 Chief Scientific Officer 22 May 2025, 13:19
APLS Apellis Pharmaceuticals, Inc. 29 Jan 2025 1 -$24,386 4 Chief Scientific Officer 30 Jan 2025, 12:07
APLS Apellis Pharmaceuticals, Inc. 22 Jan 2025 1 -$120,120 4 Chief Scientific Officer 23 Jan 2025, 15:25
APLS Apellis Pharmaceuticals, Inc. 17 Jan 2025 2 -$22,469 4 Chief Scientific Officer 21 Jan 2025, 16:02
APLS Apellis Pharmaceuticals, Inc. 13 Jan 2025 1 -$65,670 4 Chief Scientific Officer 14 Jan 2025, 16:14
APLS Apellis Pharmaceuticals, Inc. 20 May 2024 2 +$92,120 4 Chief Scientific Officer 21 May 2024, 16:03
APLS Apellis Pharmaceuticals, Inc. 08 May 2024 5 -$3,001,759 4 Chief Scientific Officer 09 May 2024, 17:15
APLS Apellis Pharmaceuticals, Inc. 08 Apr 2024 4 -$3,483,763 4 Chief Scientific Officer 09 Apr 2024, 16:25
APLS Apellis Pharmaceuticals, Inc. 08 Mar 2024 5 -$4,043,926 4 Chief Scientific Officer 11 Mar 2024, 16:08
APLS Apellis Pharmaceuticals, Inc. 12 Feb 2024 1 -$77,796 4 Chief Scientific Officer 13 Feb 2024, 16:43
APLS Apellis Pharmaceuticals, Inc. 29 Jan 2024 1 -$56,057 4 Chief Scientific Officer 31 Jan 2024, 16:21
APLS Apellis Pharmaceuticals, Inc. 22 Jan 2024 1 -$254,329 4 Chief Scientific Officer 23 Jan 2024, 18:03
APLS Apellis Pharmaceuticals, Inc. 16 Jan 2024 3 +$541,040 4 Chief Scientific Officer 17 Jan 2024, 16:47
APLS Apellis Pharmaceuticals, Inc. 14 Nov 2023 2 +$169,200 4 Chief Scientific Officer 15 Nov 2023, 16:10
APLS Apellis Pharmaceuticals, Inc. 08 Nov 2023 3 -$520,531 4 Chief Scientific Officer 09 Nov 2023, 16:18
APLS Apellis Pharmaceuticals, Inc. 09 Oct 2023 3 -$435,165 4 Chief Scientific Officer 10 Oct 2023, 16:26
APLS Apellis Pharmaceuticals, Inc. 08 Sep 2023 3 -$465,045 4 Chief Scientific Officer 11 Sep 2023, 17:58
APLS Apellis Pharmaceuticals, Inc. 08 Aug 2023 3 -$234,525 4 Chief Scientific Officer 09 Aug 2023, 16:08
APLS Apellis Pharmaceuticals, Inc. 10 Jul 2023 3 -$965,205 4 Chief Scientific Officer 11 Jul 2023, 17:37
APLS Apellis Pharmaceuticals, Inc. 08 Jun 2023 3 -$1,046,805 4 Chief Scientific Officer 09 Jun 2023, 16:40
APLS Apellis Pharmaceuticals, Inc. 08 May 2023 3 -$1,059,285 4 Chief Scientific Officer 09 May 2023, 17:02
APLS Apellis Pharmaceuticals, Inc. 10 Apr 2023 3 -$889,125 4 Chief Scientific Officer 11 Apr 2023, 16:20
APLS Apellis Pharmaceuticals, Inc. 08 Mar 2023 3 -$716,085 4 Chief Scientific Officer 10 Mar 2023, 16:18
APLS Apellis Pharmaceuticals, Inc. 21 Feb 2023 3 -$69,908 4 Chief Scientific Officer 22 Feb 2023, 05:44
APLS Apellis Pharmaceuticals, Inc. 10 Feb 2023 1 -$58,072 4 Chief Scientific Officer 14 Feb 2023, 15:28
APLS Apellis Pharmaceuticals, Inc. 08 Feb 2023 3 -$604,005 4 Chief Scientific Officer 10 Feb 2023, 16:00
APLS Apellis Pharmaceuticals, Inc. 27 Jan 2023 1 -$43,905 4 Chief Scientific Officer 30 Jan 2023, 15:47
APLS Apellis Pharmaceuticals, Inc. 20 Jan 2023 1 -$121,068 4 Chief Scientific Officer 24 Jan 2023, 16:14
APLS Apellis Pharmaceuticals, Inc. 12 Jan 2023 2 +$1,624,298 4 Chief Scientific Officer 17 Jan 2023, 18:33
APLS Apellis Pharmaceuticals, Inc. 09 Jan 2023 3 -$503,565 4 Chief Scientific Officer 10 Jan 2023, 19:07
APLS Apellis Pharmaceuticals, Inc. 29 Dec 2022 2 +$25,690 4 Chief Scientific Officer 30 Dec 2022, 16:00
APLS Apellis Pharmaceuticals, Inc. 08 Dec 2022 3 -$520,605 4 Chief Scientific Officer 12 Dec 2022, 15:28
APLS Apellis Pharmaceuticals, Inc. 08 Nov 2022 3 -$508,245 4 Chief Scientific Officer 10 Nov 2022, 07:30
APLS Apellis Pharmaceuticals, Inc. 10 Oct 2022 3 -$640,605 4 Chief Scientific Officer 11 Oct 2022, 16:58
APLS Apellis Pharmaceuticals, Inc. 08 Sep 2022 3 -$718,365 4 Chief Scientific Officer 12 Sep 2022, 16:52
APLS Apellis Pharmaceuticals, Inc. 08 Aug 2022 3 -$700,605 4 Chief Scientific Officer 09 Aug 2022, 17:18
APLS Apellis Pharmaceuticals, Inc. 08 Jul 2022 5 -$526,005 4 Chief Scientific Officer 12 Jul 2022, 16:04
APLS Apellis Pharmaceuticals, Inc. 17 Jun 2022 2 +$88,123 4 Chief Scientific Officer 22 Jun 2022, 16:32
APLS Apellis Pharmaceuticals, Inc. 08 Jun 2022 5 -$479,685 4 Chief Scientific Officer 09 Jun 2022, 17:23
APLS Apellis Pharmaceuticals, Inc. 21 Apr 2022 5 -$167,040 4 Chief Scientific Officer 02 May 2022, 20:05
APLS Apellis Pharmaceuticals, Inc. 10 Feb 2022 1 -$49,806 4 Chief Scientific Officer 14 Feb 2022, 15:35
APLS Apellis Pharmaceuticals, Inc. 28 Jan 2022 1 -$35,927 4 Chief Scientific Officer 01 Feb 2022, 17:00
APLS Apellis Pharmaceuticals, Inc. 21 Jan 2022 2 $0 4 Chief Scientific Officer 25 Jan 2022, 15:56
APLS Apellis Pharmaceuticals, Inc. 24 Jun 2021 3 -$393,375 4 Chief Scientific Officer 25 Jun 2021, 21:48
APLS Apellis Pharmaceuticals, Inc. 24 May 2021 3 -$279,562 4 Chief Scientific Officer 25 May 2021, 16:01